Ampliphi Biosciences Corp Company Profile (NYSE:APHB)

About Ampliphi Biosciences Corp (NYSE:APHB)

Ampliphi Biosciences Corp logoAmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products. The Company is engaged in developing these phage product candidates using a discovery and development platform, which is designed for identification, characterization and manufacturing of multiple phage therapies. Each product candidate combines several chosen phages, which target a specific disease-causing bacterial pathogen, such as staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa) and clostridium difficile (C. difficile). Its product candidates include AB-SA01, AB-PA01 and AB-CD01.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:APHB
  • CUSIP: N/A
  • Web: www.ampliphibio.com
Capitalization:
  • Market Cap: $7.12 million
  • Outstanding Shares: 6,627,000
Average Prices:
  • 50 Day Moving Avg: $1.92
  • 200 Day Moving Avg: $0.99
  • 52 Week Range: $0.67 - $38.25
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.10
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: $182,999.00
  • Price / Sales: 38.93
  • Book Value: $4.03 per share
  • Price / Book: 0.27
Profitability:
  • EBIDTA: ($12,290,000.00)
  • Net Margins: -11,193.10%
  • Return on Equity: -159.06%
  • Return on Assets: -80.13%
Misc:
  • Average Volume: 1.01 million shs.
  • Short Ratio: 1.65
 
Frequently Asked Questions for Ampliphi Biosciences Corp (NYSE:APHB)

What is Ampliphi Biosciences Corp's stock symbol?

Ampliphi Biosciences Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHB."

How were Ampliphi Biosciences Corp's earnings last quarter?

Ampliphi Biosciences Corp (NYSE:APHB) released its quarterly earnings results on Monday, August, 15th. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.66) by $0.12. Ampliphi Biosciences Corp had a negative net margin of 11,193.10% and a negative return on equity of 159.06%. View Ampliphi Biosciences Corp's Earnings History.

Where is Ampliphi Biosciences Corp's stock going? Where will Ampliphi Biosciences Corp's stock price be in 2017?

1 brokers have issued 1 year price objectives for Ampliphi Biosciences Corp's shares. Their predictions range from $10.00 to $10.00. On average, they anticipate Ampliphi Biosciences Corp's share price to reach $10.00 in the next twelve months. View Analyst Ratings for Ampliphi Biosciences Corp.

Are investors shorting Ampliphi Biosciences Corp?

Ampliphi Biosciences Corp saw a drop in short interest in June. As of June 30th, there was short interest totalling 552,900 shares, a drop of 6.3% from the June 15th total of 590,027 shares. Based on an average daily volume of 279,917 shares, the short-interest ratio is presently 2.0 days. Approximately 6.6% of the company's shares are short sold.

Who are some of Ampliphi Biosciences Corp's key competitors?

Who are Ampliphi Biosciences Corp's key executives?

Ampliphi Biosciences Corp's management team includes the folowing people:

  • Jeremy Laurence Curnock-Cook, Chairman of the Board
  • Paul C. Grint M.D., Chief Executive Officer, Director
  • Steven Robert Martin, Chief Financial Officer
  • Igor P. Bilinsky Ph.D., Chief Operating Officer, Senior Vice President
  • Louis C. Drapeau CPA, Director
  • Wendy S. Johnson, Director
  • Michael S. Perry Ph.D., Director
  • Vijay B. Samant, Director

How do I buy Ampliphi Biosciences Corp stock?

Shares of Ampliphi Biosciences Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ampliphi Biosciences Corp's stock price today?

One share of Ampliphi Biosciences Corp stock can currently be purchased for approximately $1.08.


MarketBeat Community Rating for Ampliphi Biosciences Corp (NYSE APHB)
Community Ranking:  3.9 out of 5 (  )
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  12 (Vote Underperform)
Total Votes:  53
MarketBeat's community ratings are surveys of what our community members think about Ampliphi Biosciences Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Ampliphi Biosciences Corp (NYSE:APHB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (830.23% upside)

Analysts' Ratings History for Ampliphi Biosciences Corp (NYSE:APHB)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
1/24/2017Roth CapitalReiterated RatingBuyN/AView Rating Details
3/8/2016Griffin SecuritiesReiterated RatingBuyN/AView Rating Details
(Data available from 7/23/2015 forward)

Earnings

Earnings History for Ampliphi Biosciences Corp (NYSE:APHB)
Earnings by Quarter for Ampliphi Biosciences Corp (NYSE:APHB)
Earnings History by Quarter for Ampliphi Biosciences Corp (NYSE APHB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/15/2016Q216($0.66)($0.78)ViewListenView Earnings Details
5/12/2016Q116($0.68)($0.82)ViewN/AView Earnings Details
3/30/2016Q415($0.40)($0.43)ViewN/AView Earnings Details
11/18/2014($0.02)$0.06ViewN/AView Earnings Details
9/24/2014($0.02)($0.01)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ampliphi Biosciences Corp (NYSE:APHB)
Current Year EPS Consensus Estimate: $-10.600 EPS
Next Year EPS Consensus Estimate: $-11.200 EPS

Dividends

Dividend History for Ampliphi Biosciences Corp (NYSE:APHB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Ampliphi Biosciences Corp (NYSE:APHB)
Insider Trades by Quarter for Ampliphi Biosciences Corp (NYSE:APHB)
Insider Trades by Quarter for Ampliphi Biosciences Corp (NYSE:APHB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/29/2016Randal J KirkMajor ShareholderSell177,020$0.48$84,969.60View SEC Filing  
4/8/2016Jeremy Curnock CookDirectorBuy239,753$2.36$565,817.08View SEC Filing  
10/6/2015Louis DrapeauDirectorBuy10,000$4.39$43,900.00View SEC Filing  
10/5/2015Michael Scott SalkaCEOBuy4,200$4.75$19,950.00View SEC Filing  
10/5/2015Wendy S JohnsonInsiderBuy1,000$4.43$4,430.00View SEC Filing  
3/16/2015Randal J KirkMajor ShareholderBuy13,939,392$0.17$2,369,696.64View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Ampliphi Biosciences Corp (NYSE:APHB)
Latest Headlines for Ampliphi Biosciences Corp (NYSE:APHB)
Source:
DateHeadline
americanbankingnews.com logoOvaScience (OVAS) and Ampliphi Biosciences Corp (APHB) Financial Survey
www.americanbankingnews.com - July 22 at 6:50 PM
americanbankingnews.com logoShort Interest in Ampliphi Biosciences Corp (NYSE:APHB) Declines By 6.3%
www.americanbankingnews.com - July 14 at 7:04 AM
finance.yahoo.com logoAmpliPhi Biosciences Novel Approach to Treating Bacterial Infection
finance.yahoo.com - July 10 at 3:53 PM
americanbankingnews.com logoZacks: Ampliphi Biosciences Corp (NYSE:APHB) Receives Consensus Rating of "Strong Buy" from Brokerages
www.americanbankingnews.com - July 7 at 10:51 AM
finance.yahoo.com logoAmpliPhi Biosciences to Present at Bacteriophage Therapy Workshop Sponsored by the FDA and NIH
finance.yahoo.com - July 5 at 4:34 PM
finance.yahoo.com logoAPHB: New CEO to Lead New Strategic Focus
finance.yahoo.com - June 28 at 9:11 PM
americanbankingnews.com logoShort Interest in Ampliphi Biosciences Corp (APHB) Rises By 163.8%
www.americanbankingnews.com - June 26 at 6:08 PM
americanbankingnews.com logoZacks: Ampliphi Biosciences Corp (APHB) Given $4.00 Average Target Price by Brokerages
www.americanbankingnews.com - June 19 at 2:10 PM
finance.yahoo.com logoAmpliPhi Biosciences Announces Presentation and Panel Participation at BIO International Convention
finance.yahoo.com - June 14 at 10:39 AM
americanbankingnews.com logoCelyad SA (CYAD) versus Ampliphi Biosciences Corp (APHB) Head to Head Analysis
www.americanbankingnews.com - June 12 at 8:52 AM
americanbankingnews.com logoShort Interest in Ampliphi Biosciences Corp (APHB) Grows By 92.0%
www.americanbankingnews.com - June 9 at 5:18 PM
finance.yahoo.com logoAmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer
finance.yahoo.com - May 31 at 8:37 PM
finance.yahoo.com logoAmpliPhi Biosciences to Present at 7th Annual LD Micro Invitational Conference on June 6
finance.yahoo.com - May 30 at 12:41 PM
americanbankingnews.com logoAnalysts Anticipate Ampliphi Biosciences Corp (APHB) to Announce ($0.80) EPS
www.americanbankingnews.com - May 29 at 9:00 AM
americanbankingnews.com logoAmpliphi Biosciences Corp (APHB) Short Interest Down 51.5% in May
www.americanbankingnews.com - May 25 at 7:08 AM
finance.yahoo.com logoAmpliPhi Biosciences Corp. :APHB-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 3:33 PM
finance.yahoo.com logoAPHB: Changing Focus to Developing Personalized Phage Therapies…
finance.yahoo.com - May 19 at 3:33 PM
seekingalpha.com logoAmpliPhi Biosciences' (APHB) CEO Scott Salka on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 16 at 10:27 AM
finance.yahoo.com logoAmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights
finance.yahoo.com - May 16 at 10:27 AM
finance.yahoo.com logoAmpliPhi Biosciences Announces Closing of Public Offering
finance.yahoo.com - May 10 at 8:48 PM
americanbankingnews.com logoShort Interest in Ampliphi Biosciences Corp (APHB) Decreases By 73.0%
www.americanbankingnews.com - May 10 at 7:00 AM
seekingalpha.com logoBiotech Forum Daily Digest: Behind Ocular's Fall; Revisiting Progenics
seekingalpha.com - May 8 at 10:56 AM
streetinsider.com logoAmpliPhi Biosciences (APHB) Prices 6.956M Share + Warrant Offering at $1.50/Sh
www.streetinsider.com - May 6 at 1:39 AM
nasdaq.com logoMid-Day Market Update: Crude Oil Up 2%; Brightcove Shares Plummet Following Q1 Results
www.nasdaq.com - May 5 at 3:35 PM
streetinsider.com logoPre-Open Movers 05/05: (IMMU) (SNCR) (ZFGN) Higher; (APHB) (BCOV) (RGLS) Lower (more...)
www.streetinsider.com - May 5 at 3:35 PM
finance.yahoo.com logoAmpliPhi Biosciences Announces Pricing of $10.4 Million Underwritten Public Offering of Common Stock and Common Warrants
finance.yahoo.com - May 5 at 1:41 AM
americanbankingnews.com logoZacks: Ampliphi Biosciences Corp (APHB) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - May 4 at 11:00 PM
streetinsider.com logoAmpliPhi Biosciences (APHB) Announces New Strategic Emphasis on Therapies for Antibiotic-Resistant Infections
www.streetinsider.com - May 1 at 9:38 AM
finance.yahoo.com logoAmpliPhi Biosciences Announces a New Strategic Emphasis on Personalized Therapies for Serious or Life-Threatening Antibiotic-Resistant Infections
finance.yahoo.com - May 1 at 9:37 AM
finance.yahoo.com logoAPHB: Looking to Follow-up on a Successful 2016
finance.yahoo.com - April 26 at 8:44 AM
americanbankingnews.com logoAmpliphi Biosciences Corp (APHB) Short Interest Up 7.6% in April
www.americanbankingnews.com - April 25 at 9:14 PM
finance.yahoo.com logoAmpliPhi Biosciences Announces Presentation of Personalized Bacteriophage Therapy Case Study for Life-Threatening Antibiotic-Resistant Infection at Scientific Conference
finance.yahoo.com - April 25 at 10:13 AM
finance.yahoo.com logoAmpliPhi Biosciences Review of Recent FDA Feedback and Drug Pipeline
finance.yahoo.com - April 24 at 10:38 AM
americanbankingnews.com logo Ampliphi Biosciences Corp (APHB) Given $6.33 Average Target Price by Brokerages
www.americanbankingnews.com - April 18 at 10:32 AM
finance.yahoo.com logoAmpliPhi Biosciences Announces Positive Feedback from FDA on Phase 2 Development Proposal
finance.yahoo.com - April 17 at 3:31 PM
rttnews.com logoFDA Says No To INCY, ZTS Snaps Up NVET, MDXG On The Move
www.rttnews.com - April 17 at 8:34 AM
finance.yahoo.com logoAmpliPhi Biosciences Announces Planned One-for-Ten Reverse Stock Split
finance.yahoo.com - April 15 at 11:16 AM
americanbankingnews.com logoAmpliphi Biosciences Corp (APHB) Short Interest Update
www.americanbankingnews.com - April 12 at 7:05 AM
finance.yahoo.com logoAmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences
finance.yahoo.com - April 7 at 6:43 AM
americanbankingnews.com logo Analysts Set $6.33 Price Target for Ampliphi Biosciences Corp (APHB)
www.americanbankingnews.com - April 6 at 9:34 AM
us.rd.yahoo.com logoAmpliPhi Biosciences Reports 2016 Fourth-Quarter and Full-Year Results and Provides Corporate Highlights
us.rd.yahoo.com - March 28 at 10:13 AM
americanbankingnews.com logoShort Interest in Ampliphi Biosciences Corp (APHB) Declines By 3.5%
www.americanbankingnews.com - March 25 at 7:17 AM

Social

Chart

Ampliphi Biosciences Corp (APHB) Chart for Sunday, July, 23, 2017

This page was last updated on 7/23/2017 by MarketBeat.com Staff